Publications in VIVO

Co-author Network

Mariam Nawas, MD

Person

Positions

Assistant Professor, University of Chicago

Clinical Disciplines

Publications
Other
View All

Selected Publications

article
1. Molecular measurable residual disease monitoring and transplant indications in NPM1 mutated acute myeloid leukemia.. Bone marrow transplantation. 2024
2. Expedited evaluation of hereditary hematopoietic malignancies in the setting of stem cell transplantation.. Haematologica. 109:3739-3744. 2024
3. Optimization of Older Adults by a Geriatric Assessment-Guided Multidisciplinary Clinic Prior to CAR T-Cell Therapy.. Blood advances. 8:3785-3797. 2024
4. Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms.. Blood cancer journal. 14:-. 2024
5. FLT3. Annals of translational medicine. 12:-. 2024
6. Treatment outcomes of venetoclax-combination regimens for relapsed/refractory myeloid malignancies after anti-CD47-directed therapy.. Leukemia & lymphoma. 65:1-4. 2024
7. Utility or Futility? A Contemporary Approach to Allogeneic Hematopoietic Cell Transplant in TP53-Mutated MDS and AML.. Blood advances. 8:553-561. 2024
8. Socioeconomic determinants of the biology and outcomes of acute lymphoblastic leukemia in adults.. Blood advances. 8:164-171. 2024
9. Optimization of Metabolic Tumor Volume as a Prognostic Marker in CAR T-Cell Therapy for Aggressive Large B-cell NHL.. Clinical lymphoma, myeloma & leukemia. 24:83-93. 2023
10. Higher graft cell dose does not influence development of acute or chronic GVHD in haploidentical transplantation using PTCy.. Blood advances. 7:4475-4478. 2023
11. FLT3. Haematologica. 108:2234-2239. 2023
12. Linking Body Composition and Nutritional Status with CAR T-cell Efficacy.. Cancer immunology research. 11:-. 2023
13. Dynamic EASIX Scores Closely Predict Nonrelapse Mortality After Allogeneic Hematopoietic Cell Transplantation.. Blood advances. 6:5898-5907. 2022
14. The Cup Runneth Over: Treatment Strategies for Newly Diagnosed Acute Myeloid Leukemia.. JCO oncology practice. 19:-. 2022
15. CD34+ -selected hematopoietic stem cell transplant conditioned with a myeloablative regimen in patients with advanced myelofibrosis.. Bone marrow transplantation. 57:1101-1107. 2022
16. Cellular Therapy During COVID-19: Lessons Learned and Preparing for Subsequent Waves.. Transplantation and cellular therapy. 2021
17. Pilot Study of Telehealth Evaluations in Patients Undergoing Hematopoietic Cell Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2020
18. Serial comprehensive geriatric and quality of life assessments in adults age ≥ 50 years undergoing autologous hematopoietic cell transplantation.. Journal of geriatric oncology. 2020
19. The clinical implications of clonal hematopoiesis in hematopoietic cell transplantation.. Blood reviews. 2020
20. Limitation in Patient-Reported Function Is Associated with Inferior Survival in Older Adults Undergoing Autologous Hematopoietic Cell Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019
21. A Protean Protein.. Journal of hospital medicine. 2018
22. Complicated necrotizing otitis externa.. American journal of otolaryngology. 2013
document
1. Real World Predictors of Response and 24-month survival in high-grade TP53-mutated Myeloid Neoplasms 2024